Trading Options with an Edge
Select Page

FIXX

Search by
TICKER SYMBOL

Homology Medicines Inc

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing

8.48

0.58

(7.342%)

Volume:

1,329,431

52 week range:

5.94 - 15.24

Market Cap:

484.107M

Company Description:

Homology Medicines, Inc. is a clinical-stage genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Homology's proprietary platform is designed to utilize its human hematopoietic stem cell-derived adeno-associated virus vectors (AAVHSCs) to precisely and efficiently deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a broad range of genetic disorders. Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on rare diseases, and intellectual property covering its family of 15 AAVHSCs. Homology believes that its compelling preclinical data, scientific expertise, product development strategy, manufacturing capabilities and intellectual property position it as a leader in the development of genetic medicines.